education
Download App
Thailand
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Thailand
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Advertisement
Advertisement
MIMS home
Drugs
Info
Lesflam
Lesflam
diclofenac
Manufacturer:
Unison
Distributor:
Medline
Marketer:
B.Grimm Pharma
Concise Prescribing Info
Contents
Diclofenac K
Indications/Uses
Post-op pain & inflammation, dysmenorrhea, migraine attacks, non-articular rheumatism, post-traumatic inflammatory states.
Dosage/Direction for Use
Adult
25-50 mg tid.
Childn ≥14 yr
75-100 mg daily in divided doses.
Administration
Should be taken with food: Take immediately after meals.
Contraindications
Peptic ulcer.
Special Precautions
History of GI disease, asthma, impaired hepatic, cardiac or renal function. Porphyria. Elderly.
Adverse Reactions
GI disorders & bleeding, headache, dizziness, vertigo, rash. Rarely, peptic ulcer, abnormalities in renal function, hepatitis, hypersensitivity.
View
ADR Reporting Link
Drug Interactions
Anticoagulants, oral antidiabetics, quinolones, cyclosporin. Increases plasma conc of lithium, MTX, digoxin. May reduce effects of diuretics.
MIMS Class
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
ATC Classification
M01AB05 - diclofenac ; Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products.
Thai FDA Category
D
Presentation/Packing
Form
Lesflam FC tab 25 mg
Packing/Price
50 × 10's
Form
Lesflam FC tab 50 mg
Packing/Price
10 × 10's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Sign up for Free to Continue Reading
Continue with Google
Sign up with email
Already a member?
Sign in
Sign up for Free to Continue Reading
Continue with Google
Sign up with email
Already a member?
Sign in